[1]吕靖,张一帆.核素分子显像监测胚胎干细胞及诱导性多潜能干细胞移植的研究进展[J].国际放射医学核医学杂志,2014,38(2):106-109.[doi:10.3760/cma.j.issn.1673-4114.2014.02.009]
　Lyu Jing,Zhang Yifan.Advances in radionuclide imaging of monitoring embryonic stem cells and induced pluripotent stem cells transplantation[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(2):106-109.[doi:10.3760/cma.j.issn.1673-4114.2014.02.009]
点击复制

核素分子显像监测胚胎干细胞及诱导性多潜能干细胞移植的研究进展(/HTML)
分享到：

《国际放射医学核医学杂志》[ISSN:1673-4114/CN:12-1381/R]

卷:
38
期数:
2014年第2期
页码:
106-109
栏目:
出版日期:
2014-03-25

文章信息/Info

Title:
Advances in radionuclide imaging of monitoring embryonic stem cells and induced pluripotent stem cells transplantation
作者:
吕靖;  张一帆
上海交通大学医学院附属瑞金医院核医学科, 200025
Author(s):
Lyu Jing;  Zhang Yifan
Department of Nuclear Medicine, Ruijin Hospital, Medical College of Shanghai Jiaotong University, Shanghai 200025, China
关键词:
干细胞移植; 多潜能干细胞; 放射性核素显像; 分子影像学
Keywords:
Stem cell transplantation; Pluripotent stem cells; Radionuclide imaging; Molecular imaging
DOI:
10.3760/cma.j.issn.1673-4114.2014.02.009
摘要:
胚胎干细胞(ESCs)具有分化成多种细胞的能力,而由转录因子转染体细胞获得的诱导性多潜能干细胞(iPSCs)具有与ESCs相似的生物学特性,且不涉及伦理学相关问题,在干细胞治疗领域得到广泛的应用。近年来,干细胞移植治疗的分子影像学监测得到了快速发展,并取得了显著的成果。该文仅就核素分子显像监测ESCs及iPSCs移植的研究进展进行综述。
Abstract:
Embryonic stem cells (ESCs)possess the ability to differentiate into various cell types.Induced pluripotent stem cells (iPSCs)are a type of pluripotent stem cell genetically reprogrammed from somatic cells,which have similar biological features of natural pluripotent stem cells,such as ESCs.iPSCs have been widely used in stem cell therapy without any drawbacks of ethical issues.In recent years,there is a growing body of studies concerning molecular imaging of monitoring stem cells transplantation and made significant achievements.This review will be focused on the updated application of radionuclide imaging in monitoring of ESCs and iPSCs transplantation.

参考文献/References:

[1] Bajada S, Mazakova I, Richardson JB, et al. Updates on stem cells and their applications in regenerative medicine[J]. 1 Tissue Eng Regen Med, 2008, 2(4):169-183.
[2] Kolios G, Moodley Y. Introduction to stem cells and regenerative medicine[J].Respiration, 2013, 85(1):3-10.
[3] Kadota S, Aiba K, Nakatsuji N. Embryonic stem cell research[J].Nihon Rinsho, 2011, 69(12):2109-2113.
[4] Luong MX, Smith KP, Stein GS. Human embryonic stem cell registries:value, challenges and opportunities[J]. J Cell Biochem, 2008,105(3):625-632.
[5] Chen X. Stem cells:what can we learn from flies?[J]. Fly(Austin), 2008, 2(1):19-28.
[6] Simpson DL, Boyd NL, Kaushal S, et al. Use of human embryonic stem cell derived-mesenchymal cells for cardiac repair[J]. Biotechnol Bioeng, 2012, 109(1):274-283.
[7] Muramatsu S, Okuno T, Suzuki Y, et al. Multitracer assessment of dopamine function after transplantation of embryonic stem cell-derived neural stem cells in a primate model of Parkinson’s disease[J]. Synapse, 2009, 63(7):541-548.
[8] Rezania A, Bruin JE, Riedel MJ, et al. Maturation of human embryonic stem cell-derived pancreatic progenitors into functional islets capable of treating preexisting diabetes in mice[J]. Diabetes, 2012, 61(8):2016-2029.
[9] Bottai D, Cigognini D, Madaschi L, et al. Embryonic stem cells promote motor recovery and affect inflammatory cell infiltration in spinal cord injured mice[J]. Exp Neurol, 2010, 223(2):452-463.
[10] Moller MS. Human embryonic stem cell research, justice, and the problem of unequal biological access[J]. Philos Ethics Humanit Med, 2008, 3:22.
[11] Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors[J]. Cell,2006, 126(4):663-676.
[12] Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors[J]. Cell, 2007,131(5):861-872.
[13] Yu J, Vodyanik MA, Smuga-Otto K, et al. Induced pluripotent stem cell lines derived from human somatic cells[J]. Science, 2007, 318(5858):1917-1920.
[14] Kuchmiy AA, Efimov GA, Nedospasov SA. Methods for in vivo molecular imaging[J]. Biochemistry (Mosc), 2012, 77(12):1339-1353.
[15] Welling MM, Duijvestein M, Signore A, et al. In vivo biodistribution of stem cells using molecular nuclear medicine imaging[J]. J Cell Physiol, 2011, 226(6):1444-1452.
[16] Wolfs E, Struys T, Notelaers T, et al. 18F-FDG labeling of mesenchymal stem cells and multi potent adult progenitor cells for PET imaging:effects on ultrastructure and differentiation capacity[J]. J Nucl Med, 2013, 54(3):447-454.
[17] Cai W, Zhang Y, Kamp TJ. Imaging of induced pluripotent stem cells:from cellular reprogramming to transplantation[J]. Am J Nucl Med Mol Imaging, 2011, 1(1):18-28.
[18] Gu E, Chen WY, Gu J, et al. Molecular imaging of stem cells:tracking survival, biodistribution, tumorigenicity, and immunogenicity[J]. Theranostics, 2012, 2(4):335-345.
[19] Jiang H, Cheng Z, Tian M, et al. In vivo imaging of embryonic stem cell therapy[J]. Eud Nucl Med Mol Imaging, 2011, 38(4):774-784.
[20] Tarantal AF, Lee CC, Batchelder CA, et al. Radiolabeling and in vivo imaging of transplanted renal lineages differentiated from human embryonic stem cells in fetal rhesus monkeys[J]. Mol Imaging Biol, 2012,14(2):197-204.
[21] Qiao H, Zhang H, Zheng Y, et al. Embryonic stem cell grafting in normal and infarcted myocardium:serial assessment with MR imaging and PET dual detection[J]. Radiology, 2009, 250(3):821-829.
[22] Lee AS, Wu JC. Imaging of embryonic stem cell migration in vivo[J]. Methods Mol Biol, 2011, 750:101-114.
[23] Wang J, Chao F, Han F, et al. PET demonstrates functional recovery after transplantation of induced pluripotent stem cells in a rat model of cerebral ischemic injury[J]. J Nucl Med, 2013, 54(5):785-792.
[24] Templin C, Zweigerdt R, Schwanke K, et al. Transplantation and tracking of human-induced pluripotent stem cells in a pig model of myocardial infarction:assessment of cell survival, engraftment, and distribution by hybrid single photon emission computed tomography/computed tomography of sodium iodide symporter transgene expression[J]. Circulation, 2012, 126(4):430-439.
[25] Lee AS, Xu D, Plews JR, et al. Preclinical derivation and imaging of autologously transplanted canine induced pluripotent stem cells[J]. J Biol Chem, 2011, 286(37):32697-32704.
[26] Cai W, Niu G, Chen X. Imaging of integrins as biomarkers for tumor angiogenesis[J]. Curr Pharm Des, 2008,14(28):2943-2973.
[27] Liu Z, Wang F, Chen X. Integrin αvβ3-targeted cancer therapy[J].Drug Dev Res,2008,69(6):329-339.
[28] Cao F, Li Z, Lee A, et al. Noninvasive de novo imaging of human embryonic stem cell-derived teratoma formation[J]. Cancer Res, 2009,69(7):2709-2713.
[29] Li Y, Liu Z, Dong C, et al. Noninvasive detection of human-induced pluripotent stem cell (hiPSC)-derived teratoma with an integrintargeting agent 99mTc-3PRGD2[J]. Mol Imaging Biol, 2013, 15(1):58-67.
[30] Pomper MG, Hammond H, Yu X, et al. Serial imaging of human embryonic stem-cell engraftment and teratoma formation in live mouse models[J]. Cell Res, 2009,19(3):370-379.

相似文献/References:

[1]裴之俊,张永学.报告基因显像监测干细胞治疗的研究进展[J].国际放射医学核医学杂志,2010,34(2):73.[doi:10.3760/cma.j.issn.1673-4114.2010.02.002]
　PEI Zhi-jun,ZHANG Yong-xue.Advances of reporter gene imaging monitoring stem cell therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2010,34(2):73.[doi:10.3760/cma.j.issn.1673-4114.2010.02.002]
[2]方圣伟,奚望,张宏.分子核医学的发展和应用前景[J].国际放射医学核医学杂志,2009,33(6):321.[doi:10.3760/cma.j.issn.1673-4114.2009.06.001]
　FANG Sheng-wei,XI Wang,ZHANG Hong.The developments and applications of molecular nuclear medicine[J].International Journal of Radiation Medicine and Nuclear Medicine,2009,33(2):321.[doi:10.3760/cma.j.issn.1673-4114.2009.06.001]

备注/Memo

备注/Memo:
收稿日期:2013-08-02;改回日期:。
基金项目:国家自然科学基金(81171367,30570525);上海市教委科研创新项目(12YZ041)
通讯作者:张一帆(Email:zhang_yifan@126.com)
更新日期/Last Update: 1900-01-01